Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of CEdiranib in the Prevention of Bowel Perforation in Platinum-resistant Ovarian Cancer

NCT07648745 is registered in ClinicalTrials.gov with Prof Gordon Jayson as lead sponsor.

NCT NCT07648745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07648745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of CEdiranib in the Prevention of Bowel Perforation in Platinum-resistant Ovarian Cancer
Lead sponsor
Prof Gordon Jayson
Phase
Phase 2
Overall status
Completed
Start date
May 14, 2018
Completion date
January 14, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel obstruction, fallopian tube cancer, ovarian cancer, primary peritoneal cancer